Shares of Sysmex Corporation ADR (OTCMKTS:SSMXY - Get Free Report) gapped down before the market opened on Wednesday . The stock had previously closed at $16.65, but opened at $16.13. Sysmex shares last traded at $16.80, with a volume of 749 shares changing hands.
Sysmex Stock Up 1.1%
The company has a quick ratio of 2.30, a current ratio of 2.97 and a debt-to-equity ratio of 0.12. The company has a market capitalization of $10.63 billion, a PE ratio of 30.14 and a beta of 1.14. The business's 50 day simple moving average is $17.09 and its 200 day simple moving average is $18.05.
Sysmex (OTCMKTS:SSMXY - Get Free Report) last posted its quarterly earnings data on Wednesday, May 14th. The company reported $0.12 EPS for the quarter, missing analysts' consensus estimates of $0.16 by ($0.04). Sysmex had a net margin of 10.56% and a return on equity of 11.81%. The firm had revenue of $958.89 million for the quarter, compared to analysts' expectations of $991.22 million. As a group, analysts forecast that Sysmex Corporation ADR will post 0.57 EPS for the current year.
About Sysmex
(
Get Free Report)
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.
Read More
Before you consider Sysmex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sysmex wasn't on the list.
While Sysmex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
